SALIX PHARMACEUTICALS LTD DEL
SLXP
SLXP was delisted on the 31st of March, 2015.
346 hedge funds and large institutions have $7.99B invested in SALIX PHARMACEUTICALS LTD DEL in 2014 Q4 according to their latest regulatory filings, with 96 funds opening new positions, 120 increasing their positions, 112 reducing their positions, and 94 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 112
2% more first-time investments, than exits
New positions opened: 96 | Existing positions closed: 94
1% less funds holding
Funds holding: 348 → 346 (-2)
24% less capital invested
Capital invested by funds: $10.6B → $7.99B (-$2.57B)
26% less funds holding in top 10
Funds holding in top 10: 19 → 14 (-5)
41% less call options, than puts
Call options by funds: $231M | Put options by funds: $389M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Paulson & Co
New York
|
+$703M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$181M |
| 3 |
Morgan Stanley
New York
|
+$156M |
| 4 |
O
OppenheimerFunds
New York
|
+$143M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$109M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$496M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$489M |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
-$159M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$119M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$116M |
SLXP Hedge Fund Activity: Q4 2014 in Review
346 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q4 2014, worth a combined $7.99B — down 24% from $10.6B a quarter earlier.
Buyers outnumbered sellers: 96 funds opened new SLXP positions and 94 closed out — a net gain of 2 holders — while 120 added to existing stakes and 112 trimmed.
The largest buyer was Paulson & Co, opening a new position worth an estimated $703M. The largest seller was Wellington Management Group, cutting an estimated $496M.
- 346 institutional investors held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q4 2014, down from 348 in Q3 2014.
- Funds reported $7.99B of SALIX PHARMACEUTICALS LTD DEL stock for Q4 2014, down 24% quarter-over-quarter.
- 96 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q4 2014 and 94 closed out, a net change of +2 holders.
- The largest SALIX PHARMACEUTICALS LTD DEL buyer in Q4 2014 was Paulson & Co, an estimated $703M added.
- The largest SALIX PHARMACEUTICALS LTD DEL seller in Q4 2014 was Wellington Management Group, an estimated $496M sold.
Based on aggregated 13F filings for Q4 2014.